Resultados de procura - Mariano Ponz‐Sarvisé

Limitar resultados
  1. 1
    Revisiting Interleukin-12 as a Cancer Immunotherapy Agent

    Revisiting Interleukin-12 as a Cancer Immunotherapy Agent por Pedro Berraondo, Iñaki Etxeberría, Mariano Ponz‐Sarvisé, Ignacio Melero

    Publicado 2018
    Ligazón do recurso Ligazón do recurso
    Carta
    Engadir a favoritos
    Gardado en:
  2. 2
    Safety and Tolerability of Immune Checkpoint Inhibitors (PD-1 and PD-L1) in Cancer

    Safety and Tolerability of Immune Checkpoint Inhibitors (PD-1 and PD-L1) in Cancer por Iosune Baraibar, Ignacio Melero, Mariano Ponz‐Sarvisé, Eduardo Castañón

    Publicado 2019
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  3. 3
    Clinical presentation, diagnosis and staging of cholangiocarcinoma

    Clinical presentation, diagnosis and staging of cholangiocarcinoma por Alejandro Forner, Gianpaolo Vidili, Marco Rengo, Luís Bujanda, Mariano Ponz‐Sarvisé, Ángela Lamarca

    Publicado 2019
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  4. 4
    Advancing pancreatic cancer research and therapeutics: the transformative role of organoid technology

    Advancing pancreatic cancer research and therapeutics: the transformative role of organoid technology por Jihao Xu, Minh Duc Pham, Vincenzo Corbo, Mariano Ponz‐Sarvisé, Tobiloba E. Oni, Daniel Öhlund, Chang‐Il Hwang

    Publicado 2025
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  5. 5
    TGFBI expression is associated with a better response to chemotherapy in NSCLC

    TGFBI expression is associated with a better response to chemotherapy in NSCLC por Marta Irigoyen, María J. Pajares, Jackeline Agorreta, Mariano Ponz‐Sarvisé, Elisabeth Salvo, María D. Lozano, Rubén Pı́o, Ignacio Gil‐Bazo, Ana Rouzaut

    Publicado 2010
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  6. 6
    Cytokines in clinical cancer immunotherapy

    Cytokines in clinical cancer immunotherapy por Pedro Berraondo, Miguel F. Sanmamed, María C. Ochoa, Iñaki Etxeberría, M. Ángela Aznar, Jose Luis Pérez‐Gracia, María E. Rodríguez-Ruiz, Mariano Ponz‐Sarvisé, Eduardo Castañón, Ignacio Melero

    Publicado 2018
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  7. 7
    Paradigms on Immunotherapy Combinations with Chemotherapy

    Paradigms on Immunotherapy Combinations with Chemotherapy por Diego Salas‐Benito, Jose Luis Pérez‐Gracia, Mariano Ponz‐Sarvisé, María E. Rodríguez-Ruiz, Iván Martínez‐Forero, Eduardo Castañón, José M. López-Picazo, Miguel F. Sanmamed, Ignacio Melero

    Publicado 2021
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  8. 8
    Role of histological regression grade after two neoadjuvant approaches with or without radiotherapy in locally advanced gastric cancer

    Role of histological regression grade after two neoadjuvant approaches with or without radiotherapy in locally advanced gastric cancer por P. Martin Romano, J. Šola, Juan A. Díaz-González, Á. Chopitea, Yohana Iragorri, Fernando Martínez-Regueira, Mariano Ponz‐Sarvisé, Leire Arbea, João Subtil, David Cano, Lucía Ceniceros, Jairo Legaspi, Jose Luis Hernández‐Davó, Javier Rodríguez

    Publicado 2016
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  9. 9
    Inhibitor of Differentiation-1 as a Novel Prognostic Factor in NSCLC Patients with Adenocarcinoma Histology and Its Potential Contribution to Therapy Resistance

    Inhibitor of Differentiation-1 as a Novel Prognostic Factor in NSCLC Patients with Adenocarcinoma Histology and Its Potential Contribution to Therapy Resistance por Mariano Ponz‐Sarvisé, Paul Nguewa, María J. Pajares, Jackeline Agorreta, María D. Lozano, Miriam Redrado, Rubén Pı́o, Carmen Behrens, Ignacio I. Wistuba, Carlos E. García-Franco, Jesús García‐Foncillas, Luis M. Montuenga, Alfonso Calvo, Ignacio Gil‐Bazo

    Publicado 2011
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  10. 10
    TGFβ Blockade Enhances Radiotherapy Abscopal Efficacy Effects in Combination with Anti-PD1 and Anti-CD137 Immunostimulatory Monoclonal Antibodies

    TGFβ Blockade Enhances Radiotherapy Abscopal Efficacy Effects in Combination with Anti-PD1 and Anti-CD137 Immunostimulatory Monoclonal Antibodies por María E. Rodríguez-Ruiz, Inmaculada Rodríguez, Lina Mayorga, Tania Labiano, Benigno Barbés, Iñaki Etxeberría, Mariano Ponz‐Sarvisé, Arantza Azpilikueta, Elixabet Bolaños, Miguel F. Sanmamed, Pedro Berraondo, Felipe A. Calvo, Mary Helen Barcellos‐Hoff, Jose Luis Pérez‐Gracia, Ignacio Melero

    Publicado 2019
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  11. 11
    Liver Resection and Transplantation Following Yttrium-90 Radioembolization for Primary Malignant Liver Tumors: A 15-Year Single-Center Experience

    Liver Resection and Transplantation Following Yttrium-90 Radioembolization for Primary Malignant Liver Tumors: A 15-Year Single-Center Experience por Daniel Aliseda, Pablo Martí‐Cruchaga, Gabriel Zozaya, Macarena Rodríguez‐Fraile, José Ignacio Bilbao, Alberto Benito, Antonio Martínez-Cuesta, L. López-Olaondo, Francisco Hidalgo, Mariano Ponz‐Sarvisé, Á. Chopitea, Javier Rodríguez, Mercedes Iñarrairaegui, J.I. Herrero, Fernando Pardo, Bruno Sangro, Fernando Rotellar

    Publicado 2023
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  12. 12
    A randomized phase II clinical trial of dendritic cell vaccination following complete resection of colon cancer liver metastasis

    A randomized phase II clinical trial of dendritic cell vaccination following complete resection of colon cancer liver metastasis por Javier Rodríguez, Eduardo Castañón, Jose Luis Pérez‐Gracia, Inmaculada Rodríguez, A. Viúdez, Carlos Alfaro, Carmen Oñate, Guiomar Pérez, Fernando Rotellar, Susana Inogès, Ascensión López-Dı́az de Cerio, L. Resano, Mariano Ponz‐Sarvisé, María E. Rodríguez-Ruiz, Á. Chopitea, Ruth Vera, Ignacio Melero

    Publicado 2018
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  13. 13
    Three-dimensional colon cancer organoids model the response to CEA-CD3 T-cell engagers

    Three-dimensional colon cancer organoids model the response to CEA-CD3 T-cell engagers por Álvaro Teijeira, Itziar Miguéliz, Saray Garasa, Vaios Karanikas, Carlos Luri‐Rey, Asunta Cirella, Irene Olivera, Marta Cañamero, Maite Álvarez, María C. Ochoa, Ana Rouzaut, María E. Rodríguez-Ruiz, Miguel F. Sanmamed, Christian Klein, Pablo Umaña, Mariano Ponz‐Sarvisé, Marina Bacac, Ignacio Melero

    Publicado 2022
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  14. 14
    LAMC2 Regulates Key Transcriptional and Targetable Effectors to Support Pancreatic Cancer Growth

    LAMC2 Regulates Key Transcriptional and Targetable Effectors to Support Pancreatic Cancer Growth por Oihane Erice, Shruthi Narayanan, Iker Feliu, Rodrigo Entrialgo‐Cadierno, Antonia Malinova, Caterina Vicentini, Elizabeth Guruceaga, Pietro Delfino, Marija Trajkovic‐Arsic, Haritz Moreno, Karmele Valencia, Ester Blanco, Irati Macaya, Daniel Öhlund, Purvesh Khatri, Fernando Lecanda, Aldo Scarpa, Jens T. Siveke, Vincenzo Corbo, Mariano Ponz‐Sarvisé, Silvestre Vicent

    Publicado 2023
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  15. 15
    Identification of Resistance Pathways Specific to Malignancy Using Organoid Models of Pancreatic Cancer

    Identification of Resistance Pathways Specific to Malignancy Using Organoid Models of Pancreatic Cancer por Mariano Ponz‐Sarvisé, Vincenzo Corbo, Hervé Tiriac, Dannielle D. Engle, Kristopher K. Frese, Tobiloba E. Oni, Chang‐Il Hwang, Daniel Öhlund, Iok In Christine Chio, Lindsey A. Baker, Dea Filippini, Kevin Wright, Tashinga E. Bapiro, Pearl S. Huang, Paul D. Smith, Kenneth H. Yu, Duncan I. Jodrell, Youngkyu Park, David A. Tuveson

    Publicado 2019
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  16. 16
    Combined immunotherapy encompassing intratumoral poly-ICLC, dendritic-cell vaccination and radiotherapy in advanced cancer patients

    Combined immunotherapy encompassing intratumoral poly-ICLC, dendritic-cell vaccination and radiotherapy in advanced cancer patients por María E. Rodríguez-Ruiz, Jose Luis Pérez‐Gracia, Inmaculada Rodríguez, Carlos Alfaro, Carmen Oñate, G. Pérez, Ignacio Gil‐Bazo, Alberto Benito, Susana Inogès, Ascensión López‐Díaz de Cerio, Mariano Ponz‐Sarvisé, L. Resano, Pedro Berraondo, Benigno Barbés, Salvador Martín‐Algarra, Alfonso Gúrpide, Miguel F. Sanmamed, Carlos de Andrea, Andres Μ. Salazar, Ignacio Melero

    Publicado 2018
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  17. 17
    Motixafortide and Pembrolizumab Combined to Nanoliposomal Irinotecan, Fluorouracil, and Folinic Acid in Metastatic Pancreatic Cancer: The COMBAT/KEYNOTE-202 Trial

    Motixafortide and Pembrolizumab Combined to Nanoliposomal Irinotecan, Fluorouracil, and Folinic Acid in Metastatic Pancreatic Cancer: The COMBAT/KEYNOTE-202 Trial por Bruno Bockorny, Teresa Macarulla, Valerya Semenisty, Erkut Borazanci, Jaime Feliú, Mariano Ponz‐Sarvisé, David Gutiérrez Abad, Paul E. Oberstein, Angela Alistar, Andrés Muñoz, Ravit Geva, Carmen Guillén‐Ponce, Mercedes Salgado Fernández, Amnon Peled, Marya Chaney, Irit Gliko‐Kabir, Liron Shemesh-Darvish, Debby Ickowicz, Ella Sorani, Shaul Kadosh, Abi Vainstein‐Haras, Manuel Hidalgo

    Publicado 2021
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  18. 18
    An integrative approach unveils FOSL1 as an oncogene vulnerability in KRAS-driven lung and pancreatic cancer

    An integrative approach unveils FOSL1 as an oncogene vulnerability in KRAS-driven lung and pancreatic cancer por Adrián Vallejo, Naiara Perurena, Elizabeth Guruceaga, Paweł K. Mazur, Susana Martínez-Canarias, Carolina Zandueta, Karmele Valencia, Andrea Arricibita, Dana M. Gwinn, Leanne C. Sayles, Chen-Hua Chuang, Laura Guembe, Peter J. Bailey, David K. Chang, Andrew V. Biankin, Mariano Ponz‐Sarvisé, Jesper B. Andersen, Purvesh Khatri, Aline Bözec, E. Alejandro Sweet‐Cordero, Julien Sage, Fernando Lecanda, Silvestre Vicent

    Publicado 2017
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  19. 19
    Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer

    Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer por Daniel Öhlund, Abram Handly-Santana, Giulia Biffi, Ela Elyada, Ana S. Almeida, Mariano Ponz‐Sarvisé, Vincenzo Corbo, Tobiloba E. Oni, Stephen Hearn, Eun Jung Lee, Iok In Christine Chio, Chang‐Il Hwang, Hervé Tiriac, Lindsey A. Baker, Dannielle D. Engle, Christine Feig, Anne Kultti, Mikala Egeblad, Douglas T. Fearon, James M. Crawford, Hans Clevers, Youngkyu Park, David A. Tuveson

    Publicado 2017
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  20. 20
    FOSL1 promotes cholangiocarcinoma via transcriptional effectors that could be therapeutically targeted

    FOSL1 promotes cholangiocarcinoma via transcriptional effectors that could be therapeutically targeted por Adrián Vallejo, Oihane Erice, Rodrigo Entrialgo‐Cadierno, Iker Feliu, Elizabeth Guruceaga, María J. Perugorría, Paula Olaizola, Alexandra Muggli, Irati Macaya, Michael R. O’Dell, Borja Ruiz‐Fernández de Córdoba, Sergio Ortiz‐Espinosa, Aram F. Hezel, Imanol Arozarena, Fernando Lecanda, Matías A. Ávila, Maite G. Fernández‐Barrena, Matthias Evert, Mariano Ponz‐Sarvisé, Diego F. Calvisi, Jesús M. Bañales, Silvestre Vicent

    Publicado 2021
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: